These 5 Boston Tech Companies Raised a Combined $600M+ in January

Learn how the tech companies that raised last month’s largest venture sums are investing the fresh capital.

Written by Ashley Bowden
Published on Feb. 03, 2025
Photo: Shutterstock
Photo: Shutterstock

Known as one of the nation’s foremost biotechnology hubs, the Boston tech scene is lively with venture funding activity for companies in the health and life science sectors. Several companies in the space pulled in millions in fresh capital to advance their technologies geared toward sustaining human life. Learn how these innovators are growing as they invest their latest financing rounds.

Top Boston Tech Funding Rounds, January 2025

  1. Aviceda Therapeutics
  2. Inari Agriculture
  3. Atalanta Therapeutics
  4. Be Biopharma
  5. Eleos Health

 

#5. $60 million, January 22

Eleos is a behavioral healthcare company offering an AI-powered technology solution that helps simplify documentation, compliance and leveraging insights to improve patient outcomes. The company raised $60 million in Series C funding led by Greenfield Partners to expand its offerings, grow its commercial team and extend its services into substance use disorder treatment centers.

 

#4. $92 million, January 15

Cambridge-based Be Biopharma engineers B Cell medicines to improve the lives of patients with Hemophilia B, other genetic diseases and cancer. Its Series C funding round came from investors including Nextech, ARCH Venture Partners and Atlas Venture. The money will help Be Biopharma advance its two lead programs and solidify its position as a clinical-stage company.

 

#3. $97 million, January 28

Atalanta Therapeutics specializes in using RNA interference to combat neurological diseases. It secured a Series B funding round to fuel Phase 1 clinical trials of its RNAi therapy candidates for KCNT1-related epilepsy and Huntington’s disease. EQT Life Sciences and Sanofi Ventures co-led the round.

 

#2. $144 million, January 7

Inari Agriculture announced $144 million in funding, led by new investors and accompanied by existing investors such as Hanwha Impact and NGS Super. Inari combines AI predictive design and gene editing to engineer soybean, corn and wheat seeds meant to enable a more sustainable, nature-positive food system. The new capital will allow Inari to fuel long-term growth.

 

#1. $207.5 million, January 7

Headquartered in Cambridge, biotech company Aviceda Therapeutics leverages nanotechnology to develop immunomodulators to help alleviate the effects of chronic inflammation. The company secured a hefty Series C financing round co-led by Omega Funds and TCGX that will support the next clinical trial phases of its product line. Its AVD-104 candidate treats geographic atrophy.

Methodology: Built In tracked the largest funding rounds of the month using previous reporting and articles from other publications and companies. This list highlights the five largest funding rounds raised in January by tech companies with a headquarters in Boston. We only include venture capital and equity raises and do not include debt or post-IPO funding rounds in this list.

Explore Job Matches.